BioXcel Therapeutics Inc (BTAI) Reports Q3 2023 Financial Results …

On November 14, 2023, BioXcel Therapeutics Inc (NASDAQ:BTAI) released its 8-K filing, announcing strategic advancements and financial results for the third quarter ended …


Install CouponFollow Chrome Extension   CouponFollow Extension

$19
OFF

BioXcel Therapeutics Inc (BTAI) Q3 2024 Earnings Call Highlights ...

6 days from now

Nov 15, 2024  · BioXcel Therapeutics Inc (BTAI) reports significant progress in pivotal trials and improved financial metrics despite revenue challenges. ... from $19.6 million in Q3 2023 to …

yahoo.com

$376000
OFF

BioXcel Therapeutics Reports Financial Results For The

6 days from now

Fourth Quarter and Full Year 2023 Financial Results Net Revenue: Net revenue from IGALMI was $376,000 for the fourth quarter of 2023, compared to $238,000 for the same period in 2022.

globenewswire.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …

6 days from now

NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence …

bioxceltherapeutics.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7M Public Offering

6 days from now

1 day ago  · BioXcel Therapeutics, Inc. (BTAI) Q3 2024 Earnings Call Transcript BioXcel announces common stock and warrants offering, no amount given BioXcel Therapeutics …

seekingalpha.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million

6 days from now

1 day ago  · NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial …

globenewswire.com

$7
OFF

BioXcel Therapeutics Announces $7M Public Offering At $0.48 Per …

6 days from now

1 day ago  · BioXcel Therapeutics (BTAI) has announced the pricing of a $7.0 million public offering, consisting of 5,600,000 shares of common stock and warrants to purchase up to …

stocktitan.net

FAQs about BioXcel Therapeutics Inc (BTAI) Reports Q3 2023 Financial Results … Coupon?

What is BioXcel Therapeutics (BTAI) doing in 2023?

BioXcel Therapeutics Inc (NASDAQ:BTAI) announced strategic advancements and financial results for the third quarter ended September 30, 2023 in its 8-K filing on November 14, 2023. The company is at the forefront of utilizing artificial intelligence for the development of transformative medicines in neuroscience and immuno-oncology. ...

What did bioxcel Therapeutics report in third quarter 2024?

BioXcel Therapeutics Reports Third Quarter 2024 Financial Results BioXcel Therapeutics Thu, Nov 14, 2024, 7:00 AM13 min read In This Article: BTAI BioXcel Therapeutics Advancing two pivotal Phase 3 trials of BXCL501 for acute treatment of agitation associated with bipolar disorders, schizophrenia, and Alzheimer’s dementia ...

What time will bioxcel Therapeutics' financial results be released?

Conferencecallset for 8:00a.m.ETtoday NEW HAVEN, Conn., Nov. 14, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced its financial results for the third quarter of 2024. ...

What time will bioxcel Therapeutics hold a conference call & webcast?

BioXcel Therapeutics will host a conference call and webcast on March 12, 2024, at 8:00 a.m. ET to provide an update on recent operational highlights and to discuss its fourth quarter and full year 2023 financial results. To access the call, please dial 877-407-5795 (domestic) or 201-689-8722 (international). ...

Is bioxcel Therapeutics a biopharmaceutical company?

NEW HAVEN, Conn., Nov. 14, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced its financial results for the third quarter of 2024. ...

What's new at bioxcel Therapeutics?

NEW HAVEN, Conn., March 12, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno-oncology, today provided an update on its late-stage TRANQUILITY and SERENITY clinical programs. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension